МЕТАСТАТИЧЕСКОЕ ПОРАЖЕНИЕ ПОЗВОНОЧНИКА НА ФОНЕ ПОЧЕЧНО-КЛЕТОЧНОГО РАКА: РЕЗУЛЬТАТЫ ЛЕЧЕНИЯ И ВЫЖИВАЕМОСТЬ ПОСЛЕ УДАЛЕНИЯ ОПУХОЛИ

Q3 Medicine
Н. С. Заборовский, С. В. Кострицкий, Дмитрий Пташников, В. И. Широкорад
{"title":"МЕТАСТАТИЧЕСКОЕ ПОРАЖЕНИЕ ПОЗВОНОЧНИКА НА ФОНЕ ПОЧЕЧНО-КЛЕТОЧНОГО РАКА: РЕЗУЛЬТАТЫ ЛЕЧЕНИЯ И ВЫЖИВАЕМОСТЬ ПОСЛЕ УДАЛЕНИЯ ОПУХОЛИ","authors":"Н. С. Заборовский, С. В. Кострицкий, Дмитрий Пташников, В. И. Широкорад","doi":"10.14531/SS2017.4.110-116","DOIUrl":null,"url":null,"abstract":"Objective. To evaluate the impact of surgical intervention and targeted therapy on the results of treatment and survival of patients with metastases of renal cell carcinoma to the spine. Material and Methods . Retrospective analysis of 100 patients (76 men, 24 women, mean age 58.4 years) with renal cell carcinoma metastases to the spine was carried out. Metastasectomy (en block resection) was performed in 39 patients, palliative decompression and stabilization — in 61. Twenty six patients received adjuvant targeted therapy (7 with metastasectomy, 19 with palliative decompression). The pain syndrome (VAS), neurological status (Frankel scale), and survival time (from the moment of surgery till the lethal outcome or the last follow-up examination) were assessed. The Kaplan – Meier survival analysis and Log-rank test were performed. A p-value < 0.05 was considered significant. Results . All patients demonstrated restoration of neurologic function and reduction of pain syndrome. There was no significant difference in survival time in patients with metastasectomy and palliative decompression (p = 0.47). Statistically significant survival benefit was observed in patients who underwent targeted therapy (p = 0.0019). Conclusion . Targeted therapy increases survival time in patients with renal cell carcinoma metastases to the spine. Metastasectomy is advisable with additional targeted therapy.","PeriodicalId":37253,"journal":{"name":"Hirurgia Pozvonochnika","volume":"14 1","pages":"110-116"},"PeriodicalIF":0.0000,"publicationDate":"2017-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hirurgia Pozvonochnika","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14531/SS2017.4.110-116","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Objective. To evaluate the impact of surgical intervention and targeted therapy on the results of treatment and survival of patients with metastases of renal cell carcinoma to the spine. Material and Methods . Retrospective analysis of 100 patients (76 men, 24 women, mean age 58.4 years) with renal cell carcinoma metastases to the spine was carried out. Metastasectomy (en block resection) was performed in 39 patients, palliative decompression and stabilization — in 61. Twenty six patients received adjuvant targeted therapy (7 with metastasectomy, 19 with palliative decompression). The pain syndrome (VAS), neurological status (Frankel scale), and survival time (from the moment of surgery till the lethal outcome or the last follow-up examination) were assessed. The Kaplan – Meier survival analysis and Log-rank test were performed. A p-value < 0.05 was considered significant. Results . All patients demonstrated restoration of neurologic function and reduction of pain syndrome. There was no significant difference in survival time in patients with metastasectomy and palliative decompression (p = 0.47). Statistically significant survival benefit was observed in patients who underwent targeted therapy (p = 0.0019). Conclusion . Targeted therapy increases survival time in patients with renal cell carcinoma metastases to the spine. Metastasectomy is advisable with additional targeted therapy.
肾细胞癌引起的脊髓转移性损伤:肿瘤切除后的治疗和存活率
目标。目的探讨手术干预和靶向治疗对肾细胞癌脊柱转移患者治疗效果和生存的影响。材料和方法。对100例肾细胞癌脊柱转移患者进行回顾性分析,其中男性76例,女性24例,平均年龄58.4岁。39例患者行转移瘤切除术,61例患者行姑息性减压和稳定。26例患者接受了辅助靶向治疗(7例转移性切除,19例姑息性减压)。评估疼痛综合征(VAS)、神经状态(Frankel评分)和生存时间(从手术时刻到致命结局或最后一次随访检查)。Kaplan - Meier生存分析和Log-rank检验。p值< 0.05被认为是显著的。结果。所有患者均表现出神经功能的恢复和疼痛综合征的减轻。转移瘤切除术与姑息性减压患者的生存时间差异无统计学意义(p = 0.47)。接受靶向治疗的患者生存获益有统计学意义(p = 0.0019)。结论。靶向治疗增加肾细胞癌转移到脊柱患者的生存时间。转移瘤切除和额外的靶向治疗是可取的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hirurgia Pozvonochnika
Hirurgia Pozvonochnika Medicine-Anesthesiology and Pain Medicine
CiteScore
0.60
自引率
0.00%
发文量
24
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信